These final results, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the principle of targeting ACKR3 as a unique way to modulate the opioid technique, which could open up new therapeutic avenues for opioid-associated disorders. Submitting this review implies https://adama703czu6.theobloggers.com/profile